Biodexa Pharmaceuticals Plc (BDRX)
0.6199
-0.01
(-2.01%)
USD |
NASDAQ |
Oct 02, 16:00
0.6101
-0.01
(-1.58%)
After-Hours: 20:00
Biodexa Pharmaceuticals Max Drawdown (5Y) : 100.0% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 100.0% |
| August 31, 2026 | 100.0% |
| July 31, 2026 | 100.0% |
| June 30, 2026 | 100.00% |
| May 31, 2026 | 100.00% |
| April 30, 2026 | 100.00% |
| March 31, 2026 | 100.00% |
| February 28, 2026 | 100.00% |
| January 31, 2026 | 100.00% |
| December 31, 2025 | 100.00% |
| November 30, 2025 | 100.00% |
| October 31, 2025 | 100.00% |
| September 30, 2025 | 100.00% |
| August 31, 2025 | 100.00% |
| July 31, 2025 | 100.00% |
| June 30, 2025 | 100.00% |
| May 31, 2025 | 100.00% |
| April 30, 2025 | 100.00% |
| March 31, 2025 | 100.00% |
| February 28, 2025 | 100.00% |
| January 31, 2025 | 100.00% |
| December 31, 2024 | 100.00% |
| November 30, 2024 | 100.00% |
| October 31, 2024 | 100.00% |
| September 30, 2024 | 100.00% |
| Date | Value |
|---|---|
| August 31, 2024 | 100.00% |
| July 31, 2024 | 100.00% |
| June 30, 2024 | 100.00% |
| May 31, 2024 | 100.00% |
| April 30, 2024 | 100.00% |
| March 31, 2024 | 100.00% |
| February 29, 2024 | 100.00% |
| January 31, 2024 | 100.00% |
| December 31, 2023 | 100.00% |
| November 30, 2023 | 100.00% |
| October 31, 2023 | 99.99% |
| September 30, 2023 | 99.99% |
| August 31, 2023 | 99.99% |
| July 31, 2023 | 99.99% |
| June 30, 2023 | 99.99% |
| May 31, 2023 | 99.99% |
| April 30, 2023 | 99.98% |
| March 31, 2023 | 99.96% |
| February 28, 2023 | 99.83% |
| January 31, 2023 | 99.82% |
| December 31, 2022 | 99.82% |
| November 30, 2022 | 99.68% |
| October 31, 2022 | 99.68% |
| September 30, 2022 | 99.68% |
| August 31, 2022 | 99.68% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| NuCana Plc | 99.99% |
| Mereo BioPharma Group Plc | 95.13% |
| BioNTech SE | 82.24% |
| Silence Therapeutics Plc | 98.33% |
| Autolus Therapeutics Plc | 96.58% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -112.07 |
| Beta (5Y) | 1.280 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 84.18% |
| Historical Sharpe Ratio (5Y) | -1.179 |
| Historical Sortino (5Y) | -1.616 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 53.78% |